Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

BMY

Bristol-Myers Squibb Company

Healthcare · USD

Set alert

Price alert · BMY

All alert types
62.48 USD +1.09 +1.78%
As of Oct 30, 2026 Extended hours 62.55 +0.11%
Bid
62.44 × 400
Ask
62.48 × 400
62.29 Day range 64.04
45.59 52-week range 68.09
YTD
+15.83%
1 year
+36.96%
Open
63.00
Prev close
61.39
Mkt cap
127.71B
Vol
12.67M
Avg vol
11.53M
EPS
4.54
P/E
13.76
Div yield
4.10%
More statistics
Low
62.29
High
64.04
Forward P/E
9.45
Beta
0.00
Short ratio
3.50
Inst. own
84.93%
Dividend
2.52
Ex-div date
Oct 1, 2026
Earnings
Feb 4, 2027
50-d avg
62.86
200-d avg
59.92
1y target
65.39

5D chart

Chart tools
Interval
1m5m15m30m
BMY five-day price chart60.061.062.063.064.0Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

2.70 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 3
  • P/B 1

Valuation

P/E 15.6×
FY 2016: 21.9×FY 2017: 100×FY 2018: 17.2×FY 2019: 31.8×FY 2020: -15.6×FY 2021: 19.8×FY 2022: 24.2×FY 2023: 13.2×FY 2024: -12.8×FY 2025: 15.6×
FY 2016 5y median 15.6× FY 2025
P/S 2.3×
FY 2016: 5.0×FY 2017: 4.9×FY 2018: 3.8×FY 2019: 4.2×FY 2020: 3.3×FY 2021: 3.0×FY 2022: 3.3×FY 2023: 2.4×FY 2024: 2.4×FY 2025: 2.3×
FY 2016 5y median 2.4× FY 2025
P/B 6.0×
FY 2016: 6.0×FY 2017: 8.6×FY 2018: 6.0×FY 2019: 2.1×FY 2020: 3.7×FY 2021: 3.9×FY 2022: 4.9×FY 2023: 3.6×FY 2024: 7.0×FY 2025: 6.0×
FY 2016 5y median 4.9× FY 2025
P/FCF 8.6×
FY 2016: 53.0×FY 2017: 23.9×FY 2018: 13.9×FY 2019: 14.8×FY 2020: 10.5×FY 2021: 9.1×FY 2022: 12.8×FY 2023: 8.4×FY 2024: 8.2×FY 2025: 8.6×
FY 2016 5y median 8.6× FY 2025
EV/EBITDA 9.7×
FY 2016: 15.5×FY 2017: 16.9×FY 2018: 12.6×FY 2019: 19.6×FY 2020: 35.9×FY 2021: 8.5×FY 2022: 9.6×FY 2023: 7.0×FY 2024: 49.1×FY 2025: 9.7×
FY 2016 5y median 9.6× FY 2025
EV/Sales 3.1×
FY 2016: 5.2×FY 2017: 5.0×FY 2018: 3.8×FY 2019: 5.5×FY 2020: 4.2×FY 2021: 3.7×FY 2022: 4.0×FY 2023: 3.0×FY 2024: 3.2×FY 2025: 3.1×
FY 2016 5y median 3.2× FY 2025
FCF Yield 11.7%
FY 2016: 1.9%FY 2017: 4.2%FY 2018: 7.2%FY 2019: 6.7%FY 2020: 9.5%FY 2021: 11.0%FY 2022: 7.8%FY 2023: 11.9%FY 2024: 12.2%FY 2025: 11.7%
FY 2016 5y median 11.7% FY 2025

Profitability

Gross Margin 71.1%
FY 2016: 74.4%FY 2017: 71.1%FY 2018: 71.3%FY 2019: 69.1%FY 2020: 72.3%FY 2021: 78.6%FY 2022: 78.0%FY 2023: 76.2%FY 2024: 71.1%FY 2025: 71.1%
FY 2016 5y median 76.2% FY 2025
Operating Margin 28.5%
FY 2016: 23.0%FY 2017: 16.6%FY 2018: 22.7%FY 2019: 22.6%FY 2020: 5.1%FY 2021: 18.4%FY 2022: 19.7%FY 2023: 18.2%FY 2024: 12.2%FY 2025: 28.5%
FY 2016 5y median 18.4% FY 2025
Net Margin 14.6%
FY 2016: 22.9%FY 2017: 4.8%FY 2018: 21.8%FY 2019: 13.2%FY 2020: -21.2%FY 2021: 15.1%FY 2022: 13.7%FY 2023: 17.8%FY 2024: -18.5%FY 2025: 14.6%
FY 2016 5y median 14.6% FY 2025
ROE 38.2%
FY 2016: 27.6%FY 2017: 8.6%FY 2018: 35.1%FY 2019: 6.7%FY 2020: -23.8%FY 2021: 19.5%FY 2022: 20.4%FY 2023: 27.3%FY 2024: -54.8%FY 2025: 38.2%
FY 2016 5y median 20.4% FY 2025
ROIC 15.0%
FY 2016: 13.2%FY 2017: 2.6%FY 2018: 16.3%FY 2019: 3.6%FY 2020: 2.1%FY 2021: 8.0%FY 2022: 9.4%FY 2023: 10.2%FY 2024: 8.3%FY 2025: 15.0%
FY 2016 5y median 9.4% FY 2025
ROA 7.8%
FY 2016: 13.2%FY 2017: 3.0%FY 2018: 14.1%FY 2019: 2.6%FY 2020: -7.6%FY 2021: 6.4%FY 2022: 6.5%FY 2023: 8.4%FY 2024: -9.7%FY 2025: 7.8%
FY 2016 5y median 6.5% FY 2025

Growth (YoY)

Revenue -0.2%
FY 2016: 17.3%FY 2017: 6.9%FY 2018: 8.6%FY 2019: 15.9%FY 2020: 62.6%FY 2021: 9.1%FY 2022: -0.5%FY 2023: -2.5%FY 2024: 7.3%FY 2025: -0.2%
FY 2016 FY 2025
Operating Income 133.1%
FY 2016: 158.2%FY 2017: -22.9%FY 2018: 48.4%FY 2019: 15.6%FY 2020: -63.2%FY 2021: 292.1%FY 2022: 6.6%FY 2023: -10.0%FY 2024: -28.2%FY 2025: 133.1%
FY 2016 FY 2025
EPS (diluted) 178.2%
FY 2016: 173.2%FY 2017: -77.0%FY 2018: 396.7%FY 2019: -33.7%FY 2020: -298.0%FY 2021: 178.4%FY 2022: -5.4%FY 2023: 30.8%FY 2024: -214.2%FY 2025: 178.2%
FY 2016 FY 2025
Free Cash Flow -7.9%
FY 2016: 43.4%FY 2017: 129.0%FY 2018: 44.9%FY 2019: 20.6%FY 2020: 80.3%FY 2021: 14.5%FY 2022: -21.6%FY 2023: 5.9%FY 2024: 10.2%FY 2025: -7.9%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 1.6×FY 2017: 1.6×FY 2018: 1.7×FY 2019: 1.6×FY 2020: 1.6×FY 2021: 1.5×FY 2022: 1.2×FY 2023: 1.4×FY 2024: 1.3×FY 2025: 1.3×
FY 2016 5y median 1.3× FY 2025
Quick Ratio 1.1×
FY 2016: 1.4×FY 2017: 1.4×FY 2018: 1.6×FY 2019: 1.4×FY 2020: 1.5×FY 2021: 1.4×FY 2022: 1.1×FY 2023: 1.3×FY 2024: 1.1×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 2.6×
FY 2016: 0.4×FY 2017: 0.7×FY 2018: 0.5×FY 2019: 0.9×FY 2020: 1.4×FY 2021: 1.3×FY 2022: 1.3×FY 2023: 1.4×FY 2024: 3.1×FY 2025: 2.6×
FY 2016 5y median 1.4× FY 2025
Net Debt / EBITDA 2.4×
FY 2016: 0.4×FY 2017: 0.4×FY 2018: 0.1×FY 2019: 4.8×FY 2020: 7.5×FY 2021: 1.6×FY 2022: 1.6×FY 2023: 1.5×FY 2024: 12.9×FY 2025: 2.4×
FY 2016 5y median 1.6× FY 2025
Interest Coverage 7.3×
FY 2016: 26.7×FY 2017: 17.6×FY 2018: 27.9×FY 2019: 9.0×FY 2020: 1.5×FY 2021: 6.4×FY 2022: 7.4×FY 2023: 7.0×FY 2024: 3.0×FY 2025: 7.3×
FY 2016 5y median 7.0× FY 2025

Dividends

Dividend Yield 4.6%
FY 2016: 2.6%FY 2017: 2.6%FY 2018: 3.1%FY 2019: 2.4%FY 2020: 2.9%FY 2021: 3.2%FY 2022: 3.0%FY 2023: 4.5%FY 2024: 4.2%FY 2025: 4.6%
FY 2016 5y median 4.2% FY 2025
Payout Ratio 71.5%
FY 2016: 57.1%FY 2017: 255.9%FY 2018: 53.1%FY 2019: 77.9%FY 2020: -45.2%FY 2021: 62.9%FY 2022: 73.2%FY 2023: 59.1%FY 2024: -54.3%FY 2025: 71.5%
FY 2016 5y median 62.9% FY 2025

Annual · latest fiscal year ends 2025-12-31